Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guided Therapeutics (GTHP)
:GTHP
GTHP Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.23
Previous CloseN/A
Volume813.00
Average Volume (3M)10.87K
Market Cap
$7.10M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.52
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding61,015,236
10 Day Avg. Volume14,116
30 Day Avg. Volume10,867
Standard Deviation0.29
R-Squared0.01
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)186.90
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Ownership Overview
27.64% Insiders
―
Mutual Funds
― Other Institutional Investors
72.36% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GTHP FAQ
What was Guided Therapeutics’s price range in the past 12 months?
Guided Therapeutics lowest stock price was $0.06 and its highest was $0.23 in the past 12 months.
What is Guided Therapeutics’s market cap?
Guided Therapeutics’s market cap is $7.10M.
When is Guided Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Guided Therapeutics’s earnings last quarter?
Guided Therapeutics released its earnings results on Aug 15, 2023. The company reported -$0.032 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.032.
Is Guided Therapeutics overvalued?
According to Wall Street analysts Guided Therapeutics’s price is currently Overvalued.
Does Guided Therapeutics pay dividends?
Guided Therapeutics does not currently pay dividends.
What is Guided Therapeutics’s EPS estimate?
Guided Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Guided Therapeutics have?
Guided Therapeutics has 61,015,236 shares outstanding.
What happened to Guided Therapeutics’s price movement after its last earnings report?
Guided Therapeutics reported an EPS of -$0.032 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Guided Therapeutics?
Currently, no hedge funds are holding shares in GTHP
---
Company Description
Guided Therapeutics
Guided Therapeutics, Inc. enagges in the development of medical devices. It focuses on the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. The company was founded by Shabbir Bakir Bambot, Mark L. Faupel, and Richard L. Fowler on October 27, 1992 and is headquartered in Norcross, GA.
---
Technical Analysis
---